Felipe B Lima, Francisco Wilker Mustafa Gomes Muniz, Gdayllon C Meneses, Karine C Bezerra, Carolyne N Moreira, André P Aguiar, José Carlos R Nascimento, Tainá Veras de S Freitas, Pedro Felipe C de Bruin, Eanes Delgado B Pereira, Elizabeth de F Daher, Reinaldo B Oriá
OBJECTIVES: COVID-19, caused by SARS-CoV-2, has spread around the world since 2019. In severe cases, COVID-19 can lead to hospitalization and death. Systemic arterial hypertension and other comorbidities are associated with serious COVID-19 infection. Literature is unclear whether antihypertensive therapy with angiotensin receptor blockers (ARBs) and angiotensin converting enzyme (ACE) inhibitors affect COVID-19 outcomes. We aim to assess whether ACEI/ARB therapy is a risk factor for worse respiratory outcomes related to COVID-19 in hospitalized patients...
November 23, 2023: Medicina Clínica